Literature DB >> 16516342

Gastric microbiota in elderly patients fed via nasogastric tubes for prolonged periods.

R Segal1, I Pogoreliuk, M Dan, Y Baumoehl, A Leibovitz.   

Abstract

Aspiration of oropharyngeal contents is a constant threat for elderly patients fed via a nasogastric tube (NGT). Colonization of the oropharynx of these patients by pathological flora and the development of biofilms on the feeding tube has been documented recently. In addition, the presence of the NGT may interfere with the gastro-oesophageal sphincter, leading to gastro-oesophageal reflux. Thus, the passage of pathogenic bacteria in both directions is facilitated. The purpose of this study was to explore the microbiota of the gastric juice and the oropharynx in NGT-fed elderly patients. Samples of gastric juice were drawn after an overnight fast, and microbial cultures and direct pH measurement were performed. Concomitant cultures were obtained from the oropharynx. Overall, 107 gastric and oropharyngeal cultures were obtained from 52 subjects. Pathogenic flora (Gram-negative bacteria or Staphylococcus aureus) were isolated from 74% of stomach samples and from 69% of oropharynx samples. Proteus spp. (26%) and Escherichia coli (22%) were the most common isolates in the gastric juice, and Proteus spp. (24%) and Pseudomonas spp. (21%) were the most common isolates in the oropharynx. Similarity in the composition of the oropharynx and gastric flora was observed in most cases. The gastric pH was relatively high (4.57 +/- 0.65 at 3 h after feeding and 4.2 +/- 0.9 at 12 h after feeding) and was highly correlated with the isolation of pathogenic bacteria (r = 0.58, P < 0.01). These results support the view that in addition to the oropharynx, the stomach of NGT-fed elderly patients constitutes a reservoir of pathogens that could be associated with the risk of aspiration pneumonia. The cause of the high gastric pH and its relation to pathogenic bacteria warrants further study.

Entities:  

Mesh:

Year:  2006        PMID: 16516342     DOI: 10.1016/j.jhin.2005.11.005

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

1.  16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora.

Authors:  Rachel Rosen; Lan Hu; Janine Amirault; Umakanth Khatwa; Doyle V Ward; Andrew Onderdonk
Journal:  J Pediatr       Date:  2015-02-04       Impact factor: 4.406

Review 2.  Proteus spp. as Putative Gastrointestinal Pathogens.

Authors:  Amy L Hamilton; Michael A Kamm; Siew C Ng; Mark Morrison
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

Review 3.  Microbial biofilms and gastrointestinal diseases.

Authors:  Erik C von Rosenvinge; Graeme A O'May; Sandra Macfarlane; George T Macfarlane; Mark E Shirtliff
Journal:  Pathog Dis       Date:  2013-01-29       Impact factor: 3.166

4.  Changes in gastric and lung microflora with acid suppression: acid suppression and bacterial growth.

Authors:  Rachel Rosen; Janine Amirault; Hongye Liu; Paul Mitchell; Lan Hu; Umakanth Khatwa; Andrew Onderdonk
Journal:  JAMA Pediatr       Date:  2014-10       Impact factor: 16.193

5.  Nasogastric enteral feeding tubes modulate preterm colonization in early life.

Authors:  J Jara Pérez; B Moreno-Sanz; I Castro Navarro; C Alba Rubio; B Chinea Jiménez; E Escribano Palomino; L Fernández Álvarez; J M Rodríguez; B Orgaz Martín; M Sáenz de Pipaón
Journal:  Pediatr Res       Date:  2021-11-29       Impact factor: 3.953

6.  Prevalence of Device-associated Nosocomial Infections Caused By Gram-negative Bacteria in a Trauma Intensive Care Unit in Libya.

Authors:  Abdulaziz Zorgani; Atef Abofayed; Abdulhakim Glia; Ashrf Albarbar; Sami Hanish
Journal:  Oman Med J       Date:  2015-07

7.  Does Anti-TNF-α Therapy Affect the Bacteriological Profile of Specimens Collected from Perianal Lesions? A Retrospective Analysis in Patients with Crohn's Disease.

Authors:  Jolanta Gruszecka; Rafał Filip
Journal:  Int J Environ Res Public Health       Date:  2022-03-02       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.